Page last updated: 16 June, 2021, 10:08am Ear, nose and oropharnx Dupilumab for chronic rhinosinusitis with nasal polyps (NICE TA648) position statement.Download Dental preparations MSEMOC position statementDownload Omalizumab for chronic rhinosinusitis with nasal polyps (NICE TA678) position statementDownload